Prime Medicine, Inc. Quarterly Assets in USD from Q4 2021 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Prime Medicine, Inc. quarterly Assets history and growth rate from Q4 2021 to Q3 2024.
Prime Medicine, Inc. Assets for the quarter ending September 30, 2024 was $333M, a 39.2% increase year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$333M	+$93.6M	+39.2%	Sep 30, 2024	10-Q	2024-11-12
Q2 2024	$260M	-$21.2M	-7.53%	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	$311M	-$5.56M	-1.76%	Mar 31, 2024	10-Q	2024-05-10
Q4 2023	$194M	-$166M	-46.2%	Dec 31, 2023	10-Q	2024-11-12
Q3 2023	$239M	+$23.9M	+11.1%	Sep 30, 2023	10-Q	2023-11-03
Q2 2023	$281M			Jun 30, 2023	10-Q	2023-08-07
Q1 2023	$317M			Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$360M	+$58.5M	+19.4%	Dec 31, 2022	10-K	2024-03-01
Q3 2022	$215M			Sep 30, 2022	10-Q	2022-11-14
Q4 2021	$302M			Dec 31, 2021	10-K	2023-03-09

* An asterisk sign (*) next to the value indicates that the value is likely invalid.